I. V. Molchanov

I. V. Molchanov

Auto-generated profile, based on publicly available information

I. V. Molchanov

V. A. Negovsky Research Institute of General Reanimatology, Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Ministry of Education and Science of Russia

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2020 in Russian Sklifosovsky Journal "Emergency Medical Care"
Verified
Journal Article
Open access
PDF file
OGOleg Aleksandrovich Grebenchikov
Oleg Aleksandrovich Grebenchikov
IMI. V. Molchanov
I. V. Molchanov
ASA. I. Shpichko
A. I. Shpichko
AYA. K. Yevseyev
A. K. Yevseyev
ASA. K. Shabanov
A. K. Shabanov
ШХШ. Ж. Хусаинов
Ш. Ж. Хусаинов
An increase in the number of patients with severe brain damage of various etiologies determines the need to improve neuroprotection technologies. The review is devoted to modern views on the mechanisms of brain protection, as well as the basic processes underlying damage to neurons. The article discusses the results of the most important experimental studies in this area using inert xenon gas. The authors analyzed a number of works highlighting neurotective properties of the xenon inhalation anesthetic in studies performed in vitro and in vivo. The main mechanisms of neuronal death depending on the type of damage are shown, the points of application of the protective effect of xenon on the brain and the prospects for further research in this area are demonstrated in the article.

22 October 2020 in Russian Sklifosovsky Journal "Emergency Medical Care"
Verified
Journal Article
Open access
PDF file
ASA. I. Shpichko
A. I. Shpichko
OGOleg Aleksandrovich Grebenchikov
Oleg Aleksandrovich Grebenchikov
IMI. V. Molchanov
I. V. Molchanov
ASA. K. Shabanov
A. K. Shabanov
NSN. P. Shpichko
N. P. Shpichko
KKK. K. Kadantseva
K. K. Kadantseva
The review presents the main aspects of the cardioprotective properties of the xenon inhalation anesthetic. Based on the analysis of publications, the article discusses modern views on the mechanisms of the protective action of xenon, realized using pre- and post-conditioning mechanisms, shows major molecular targets and their effects. The article presents the results of experimental studies in vivo and in vitro, which showed the protective effect of xenon on the myocardium and the results of recent randomized clinical trials. The analysis of studies demonstrates the ability of xenon to increase myocardial resistance to ischemia and reperfusion and opens up good prospects for its use in clinical practice in patients with a high risk of cardiac complications.

1 January 2018 in Russian Journal of Anesthesiology and Reanimatology
Verified
Journal Article
Open access
ALA. F. Lopatin
A. F. Lopatin
Ivan Valer'evich RedkinIvan Valer'evich Redkin
Ivan Valer'evich Redkin
VSV. V. Samoylenko
V. V. Samoylenko
EPE. L. Petrovskaya
E. L. Petrovskaya
IMI. V. Molchanov
I. V. Molchanov

23 April 2023 in Russian Journal of Anesthesiology and Reanimatology
Verified
Journal Article
Closed access
VPV.I. Potievskaya
V.I. Potievskaya
IZI.B. Zabolotskikh
I.B. Zabolotskikh
IGI.E. Gridchik
I.E. Gridchik
AGA.I. Gritsan
A.I. Gritsan
AEA.A. Eremenko
A.A. Eremenko
IMI.V. Molchanov
I.V. Molchanov
The authors present the recommendations for sedation of patients in intensive care units. The indications for sedative therapy, the main objectives and approaches to sedation, as well as recommendations for interrupting sedative therapy are presented. The authors discuss the principles of choosing sedative drugs, characteristics of effects and adverse events of the main sedatives. Sedative therapy in critically ill patients, including those with severe respiratory failure, status epilepticus and hypoxic encephalopathy, is described. Recommendations for prevention of excitation in ICU patients are given. The main criteria for assessing the quality of medical care are presented. When updating the recommendations, the results of Delphic examination of previous guidelines, carried out by independent experts, were used.

23 April 2023 in Russian Journal of Anesthesiology and Reanimatology
Verified
Journal Article
Closed access
KLK.M. Lebedinskii
K.M. Lebedinskii
GPG.G. Prokopiev
G.G. Prokopiev
SSS.M. Stepanenko
S.M. Stepanenko
PDP.V. Dunts
P.V. Dunts
IMI.V. Molchanov
I.V. Molchanov
SRS.I. Rostovtsev
S.I. Rostovtsev
Clinical guidelines address malignant hyperthermia, a rare pharmacogenetic syndrome triggered by volatile inhalational anesthetics and suxamethonium. Modern data concerning the mechanism of malignant hyperthermia development are presented, issues of syndrome clinical presentation and diagnosis are highlighted. Practical algorithm for anesthesiologist in case of malignant hyperthermia crisis is given, recommendations for identifying life-threatening syndromes and methods for their correction are presented. Prevention measures are also described. Medical care quality assessment criteria for the management of malignant hyperthermia patients are indicated.

16 February 2026 in General Reanimatology
Verified
Journal Article
Open access
PDF file
ALA. P. Lyangazov
A. P. Lyangazov
MGM. V. Gabitov
M. V. Gabitov
YSYu. V. Skripkin
Yu. V. Skripkin
IMI. V. Molchanov
I. V. Molchanov
OGOleg Aleksandrovich Grebenchikov
Oleg Aleksandrovich Grebenchikov
Aim of the study. To study the effect of helium-oxygen mixture on predictors of postoperative pulmonary complications in cancer patients with chronic obstructive pulmonary disease (COPD). Materials and methods. A single-center prospective clinical study with historical control included 208 patients, among them 104 patients received helium-oxygen mixture inhalations (70% helium and 30% oxygen) in the preoperative period (He group) and 104 patients were the historical control group (Ctrl group). Given the risk of bias associated with confounders, we conducted a one-to-one matching analysis based on pseudorandomization to adjust for the unbalanced baseline characteristics of the groups. We used logistic regression to develop the pseudo-randomization estimates. We used the nearest neighbor matching 1:1 with a caliper of 0.1 to achieve better similarity among matched pairs. After pseudo-randomization, we included 87 patients in each group, ensuring adequate balance across all covariates. A multivariate logistic regression analysis was performed to identify factors associated with the risk of postoperative pulmonary complications. Results. In the He group, there was a statistically significant improvement in a number of functional parameters compared to the Ctrl group. FEV1, FVC, mod. Tiffno index values in the He group increased significantly ( р = 0,0009; р = 0,0115; р = 014, respectively), gas exchange parameters (PaO₂, PaCO₂, pH, SpO₂) improved ( р = 0.0006; р = 0.004; р = 0.0097; р = 0.001, respectively). Hypoxia tolerance tests also showed significantly greater values in the He group (Stange test, р = 0.016; Sabrazes (Gench) post-exhalation breath-holding test, р = 0.024). Analysis of postoperative parameters showed significant advantage of the He group over the control group in terms of critically important clinical outcomes. At the final stage of stepwise selection, three independent predictors were included in the risk model for postoperative pulmonary complications: SpO₂, the breath-holding test, and the duration of postoperative mechanical ventilation. The quality of the model was high, with a correctly classified case rate of 92.2%, a Hosmer–Lemeshow goodness-of-fit statistic of р = 0.933, and a total model significance of p <0.000. Conclusion. We performed the first clinical study that showed the importance of preoperative preparation using a helium-oxygen mixture in cancer patients with chronic obstructive pulmonary disease and identified predictors of pulmonary complications after thoracic surgery.